$AUR
Aurora Innovation, Inc.

2021 Q1 Form 10-Q Financial Statement

#000119312521162338 Filed on May 17, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q4
Revenue $0.00 $0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $32.68M $15.07M
YoY Change
% of Gross Profit
Research & Development $159.1M $51.53M
YoY Change
% of Gross Profit
Depreciation & Amortization $5.994M
YoY Change
% of Gross Profit
Operating Expenses $191.8M $66.60M
YoY Change
Operating Profit -$191.8M
YoY Change
Interest Expense -$2.020M $75.00K
YoY Change
% of Operating Profit
Other Income/Expense, Net -$2.015M -$6.000K
YoY Change
Pretax Income -$191.3M -$66.53M
YoY Change
Income Tax -$2.644M $1.000K
% Of Pretax Income
Net Earnings -$188.6M -$66.53M
YoY Change
Net Earnings / Revenue
Basic Earnings Per Share -$0.39
Diluted Earnings Per Share -$0.39 -$66.89K
COMMON SHARES
Basic Shares Outstanding 483.6M shares
Diluted Shares Outstanding 483.6M shares

Balance Sheet

Concept 2021 Q1 2020 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $760.0K
YoY Change
Cash & Equivalents $757.6K $387.3M
Short-Term Investments
Other Short-Term Assets $1.510M
YoY Change
Inventory
Prepaid Expenses $1.506M $6.380K
Receivables
Other Receivables
Total Short-Term Assets $2.264M $406.4M
YoY Change
LONG-TERM ASSETS
Property, Plant & Equipment $10.90M
YoY Change
Goodwill $30.05M
YoY Change
Intangibles $52.70M
YoY Change
Long-Term Investments $977.5M $0.00
YoY Change
Other Assets $15.63M
YoY Change
Total Long-Term Assets $979.2M $212.4M
YoY Change
TOTAL ASSETS
Total Short-Term Assets $2.264M $406.4M
Total Long-Term Assets $979.2M $212.4M
Total Assets $981.4M $618.9M
YoY Change
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $37.95K $6.502M
YoY Change
Accrued Expenses $359.7K $3.412M
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $90.00K
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $2.016M $31.95M
YoY Change
LONG-TERM LIABILITIES
Long-Term Debt
YoY Change
Other Long-Term Liabilities $70.30M $25.00K
YoY Change
Total Long-Term Liabilities $70.30M $25.00K
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $2.016M $31.95M
Total Long-Term Liabilities $70.30M $25.00K
Total Liabilities $71.41M $132.2M
YoY Change
SHAREHOLDERS EQUITY
Retained Earnings -$1.202M -$18.62K
YoY Change
Common Stock $0.00
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $520.2M -$276.6M
YoY Change
Total Liabilities & Shareholders Equity $981.4M $618.9M
YoY Change

Cashflow Statement

Concept 2021 Q1 2020 Q4
OPERATING ACTIVITIES
Net Income -$188.6M -$66.53M
YoY Change
Depreciation, Depletion And Amortization $5.994M
YoY Change
Cash From Operating Activities -$151.0M
YoY Change
INVESTING ACTIVITIES
Capital Expenditures $3.381M
YoY Change
Acquisitions -$294.4M
YoY Change
Other Investing Activities -$977.5M
YoY Change
Cash From Investing Activities $291.1M
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $617.0K
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities $398.5M
YoY Change
NET CHANGE
Cash From Operating Activities -$151.0M
Cash From Investing Activities $291.1M
Cash From Financing Activities $398.5M
Net Change In Cash $538.6M
YoY Change
FREE CASH FLOW
Cash From Operating Activities -$151.0M
Capital Expenditures $3.381M
Free Cash Flow -$154.4M
YoY Change

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2021Q1 dei Document Type
DocumentType
10-Q
CY2021Q1 dei Amendment Flag
AmendmentFlag
false
CY2021Q1 dei Document Period End Date
DocumentPeriodEndDate
2021-03-31
CY2021Q1 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021Q1 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
Q1
CY2021Q1 dei Entity Registrant Name
EntityRegistrantName
Reinvent Technology Partners Y
CY2021Q1 dei Entity Central Index Key
EntityCentralIndexKey
0001828108
CY2021Q1 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2021Q1 dei Entity Current Reporting Status
EntityCurrentReportingStatus
No
CY2021Q1 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021Q1 dei Entity Shell Company
EntityShellCompany
true
CY2021Q1 dei Entity Small Business
EntitySmallBusiness
true
CY2021Q1 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2021Q1 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2021Q1 dei Entity File Number
EntityFileNumber
001-40216
CY2021Q1 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
98-1562265
CY2021Q1 dei Document Quarterly Report
DocumentQuarterlyReport
true
CY2021Q1 dei Document Transition Report
DocumentTransitionReport
false
CY2021Q1 dei Entity Address Address Line1
EntityAddressAddressLine1
215 Park Avenue
CY2021Q1 dei Entity Address Address Line2
EntityAddressAddressLine2
Floor 11
CY2021Q1 dei Entity Address City Or Town
EntityAddressCityOrTown
New York
CY2021Q1 dei Entity Address State Or Province
EntityAddressStateOrProvince
NY
CY2021Q1 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
10003
CY2021Q1 dei City Area Code
CityAreaCode
212
CY2021Q1 dei Local Phone Number
LocalPhoneNumber
457-1272
CY2021Q1 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
757574
CY2021Q1 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1505996
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
6380
CY2021Q1 us-gaap Assets Current
AssetsCurrent
2263570
CY2020Q4 us-gaap Assets Current
AssetsCurrent
6380
CY2020Q4 rtpy Deferred Offering Costs Non Current
DeferredOfferingCostsNonCurrent
56483
CY2021Q1 us-gaap Assets Held In Trust Noncurrent
AssetsHeldInTrustNoncurrent
977508835
CY2021Q1 us-gaap Assets
Assets
979772405
CY2020Q4 us-gaap Assets
Assets
62863
CY2021Q1 us-gaap Accounts Payable Current
AccountsPayableCurrent
37951
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
23450
CY2021Q1 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
359666
CY2020Q4 us-gaap Accrued Liabilities Current
AccruedLiabilitiesCurrent
33033
CY2021Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
36073540
CY2021Q1 us-gaap Due To Related Parties Current
DueToRelatedPartiesCurrent
89204
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
486821
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
56483
CY2021Q1 rtpy Deferred Legal Fees Non Current
DeferredLegalFeesNonCurrent
18182
CY2021Q1 rtpy Deferred Underwriting Commissions Noncurrent
DeferredUnderwritingCommissionsNoncurrent
34212500
CY2021Q1 us-gaap Liabilities
Liabilities
70791043
CY2021Q1 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
977500000
CY2021Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
295179
CY2021Q1 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
977500000
CY2021Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-977500000
CY2021Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
22250000
CY2021Q1 us-gaap Payment Of Financing And Stock Issuance Costs
PaymentOfFinancingAndStockIssuanceCosts
19600514
CY2021Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
979854307
CY2020Q4 us-gaap Liabilities
Liabilities
56483
CY2021Q1 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2021Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
903981360
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
7239434
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
22556
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-2242611
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-18620
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
5000002
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
979772405
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
62863
CY2021Q1 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q1 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
5000000
CY2021Q1 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q1 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q1 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
208506
CY2021Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
-208506
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
912840
CY2021Q1 rtpy Financing Costs Derivative Warrant Liabilities
FinancingCostsDerivativeWarrantLiabilities
1111480
CY2021Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
8835
CY2021Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-2015485
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
6380
CY2021Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
957730890
CY2021Q1 us-gaap Adjustments To Additional Paid In Capital Stock Issued Issuance Costs
AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts
53390327
CY2021Q1 rtpy Sale Of Private Placement Warrants To Sponsor In Private Placement
SaleOfPrivatePlacementWarrantsToSponsorInPrivatePlacement
6858410
CY2021Q1 rtpy Shares Subject To Possible Redemption Value
SharesSubjectToPossibleRedemptionValue
-903981360
CY2021Q1 us-gaap Net Income Loss
NetIncomeLoss
-2223991
CY2021Q1 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
912840
CY2021Q1 rtpy Financing Costs Derivative Warrant Liabilities
FinancingCostsDerivativeWarrantLiabilities
1111480
CY2021Q1 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
8835
CY2021Q1 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1499616
CY2021Q1 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
3201
CY2021Q1 us-gaap Increase Decrease In Accrued Liabilities
IncreaseDecreaseInAccruedLiabilities
18984
CY2021Q1 us-gaap Increase Decrease In Due To Related Parties Current
IncreaseDecreaseInDueToRelatedPartiesCurrent
89204
CY2021Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-1596733
CY2021Q1 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
757574
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
0
CY2021Q1 rtpy Offering Costs Included In Accounts Payable
OfferingCostsIncludedInAccountsPayable
11300
CY2021Q1 rtpy Offering Costs Included In Accrued Expenses
OfferingCostsIncludedInAccruedExpenses
307649
CY2021Q1 rtpy Offering Costs Paid By Related Party Under Promissory Note
OfferingCostsPaidByRelatedPartyUnderPromissoryNote
295179
CY2021Q1 rtpy Deferred Legal Fees
DeferredLegalFees
18182
CY2021Q1 rtpy Deferred Underwriting Commissions In Connection With The Initial Public Offering
DeferredUnderwritingCommissionsInConnectionWithTheInitialPublicOffering
34212500
CY2021Q1 rtpy Initial Value Of Class A Ordinary Shares Subject To Possible Redemption
InitialValueOfClassAOrdinarySharesSubjectToPossibleRedemption
905037840
CY2021Q1 dei Entity Incorporation Date Of Incorporation
EntityIncorporationDateOfIncorporation
2020-10-02
CY2021Q1 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
22300000
CY2021Q1 us-gaap Payments To Acquire Restricted Investments
PaymentsToAcquireRestrictedInvestments
977500000
CY2021Q1 rtpy Restricted Investment Value Per Share
RestrictedInvestmentValuePerShare
10.00
CY2021Q1 us-gaap Minority Interest Change In Redemption Value
MinorityInterestChangeInRedemptionValue
-1056480
CY2021Q1 rtpy Term Of Restricted Investments
TermOfRestrictedInvestments
P185D
CY2021Q1 us-gaap Minimum Net Worth Required For Compliance
MinimumNetWorthRequiredForCompliance
5000001
CY2021Q1 rtpy Percentage Of Public Shares To Be Redeemed In Case Business Consummation Does Not Occur
PercentageOfPublicSharesToBeRedeemedInCaseBusinessConsummationDoesNotOccur
1.00
CY2021Q1 rtpy Period Within Which Business Combination Must Be Completed From The Date Of Closure Of Initial Public Offering
PeriodWithinWhichBusinessCombinationMustBeCompletedFromTheDateOfClosureOfInitialPublicOffering
P24M
CY2021Q1 rtpy Period Within Which Business Combination Must Be Completed From The Date Of Closure Of Initial Public Offering In Case Letter Of Intent Is Executed
PeriodWithinWhichBusinessCombinationMustBeCompletedFromTheDateOfClosureOfInitialPublicOfferingInCaseLetterOfIntentIsExecuted
P27M
CY2021Q1 rtpy Period Within Which The Public Shares Shall Be Redeemed
PeriodWithinWhichThePublicSharesShallBeRedeemed
P10D
CY2021Q1 rtpy Provision For Working Capital Needs
ProvisionForWorkingCapitalNeeds
701250
CY2021Q1 us-gaap Liquidation Basis Of Accounting Accrued Costs To Dispose Of Assets And Liabilities
LiquidationBasisOfAccountingAccruedCostsToDisposeOfAssetsAndLiabilities
100000
CY2021Q1 rtpy Per Share Amount To Be Maintained In The Trust Account
PerShareAmountToBeMaintainedInTheTrustAccount
10.00
CY2021Q1 us-gaap Use Of Estimates
UseOfEstimates
<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Use of Estimates </div></div></div> <div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with U.S. GAAP requires the Company&#8217;s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting period. Making estimates requires management to exercise significant judgment. It is at least reasonably possible that the estimate of the effect of a condition, situation or set of circumstances that existed at the date of the financial statements, which management considered in formulating its estimate, could change in the near term due to one or more future confirming events. Accordingly, the actual results could differ significantly from those estimates.&#160;</div><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;">&#160;</div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2021Q1 rtpy Term Of Restricted Investments
TermOfRestrictedInvestments
P185D
CY2021Q1 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021Q1 rtpy Warrants To Be Issued Description
WarrantsToBeIssuedDescription
Each Unit consists of one Class A ordinary share and one-eighth of one redeemable warrant (&#8220;Public Warrant&#8221;). Each whole Public Warrant will entitle the holder to purchase one Class A ordinary share at an exercise price of $11.50 per share, subject to adjustment (see Note 7).
CY2020Q4 rtpy Cash Paid From Sponsor
CashPaidFromSponsor
25000
CY2020Q4 rtpy Ordinary Shares Received
OrdinarySharesReceived
2875000
CY2020Q4 rtpy Aggregate Shares Held By Sponsor
AggregateSharesHeldBySponsor
3187500
CY2021Q1 rtpy Provision For Working Capital
ProvisionForWorkingCapital
701250
CY2021Q1 rtpy Underwriting Agreement Description
UnderwritingAgreementDescription
The underwriters were entitled to an underwriting discount of $0.20 per unit, or approximately $19.6 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or approximately $34.2 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee will become payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.
CY2021Q1 rtpy Additional Sale Of Stock
AdditionalSaleOfStock
12750000
CY2021Q1 rtpy Percentage Of Shares Issuable On The Percentage Of The Total Paid Up Capital
PercentageOfSharesIssuableOnThePercentageOfTheTotalPaidUpCapital
0.20
CY2021Q1 us-gaap Class Of Warrant Or Right Exercise Price Of Warrants Or Rights1
ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1
11.50
CY2021Q1 us-gaap Warrants And Rights Outstanding Term
WarrantsAndRightsOutstandingTerm
P5Y
CY2021Q1 us-gaap Assets
Assets
981444800
CY2021Q1 us-gaap Liabilities Current
LiabilitiesCurrent
2015571
CY2021Q1 rtpy Deferred Legal Fees Non Current
DeferredLegalFeesNonCurrent
18183
CY2021Q1 rtpy Deferred Underwriting Commissions Noncurrent
DeferredUnderwritingCommissionsNoncurrent
34212500
CY2021Q1 us-gaap Derivative Liabilities Noncurrent
DerivativeLiabilitiesNoncurrent
35160700
CY2021Q1 us-gaap Liabilities
Liabilities
71406954
CY2021Q1 us-gaap Temporary Equity Carrying Amount Attributable To Parent
TemporaryEquityCarryingAmountAttributableToParent
905037840
CY2021Q1 us-gaap Preferred Stock Value
PreferredStockValue
CY2021Q1 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
6198414
CY2021Q1 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-1201577
CY2021Q1 us-gaap Stockholders Equity
StockholdersEquity
5000006
CY2021Q1 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
981444800
CY2021Q1 dei Entity Filer Category
EntityFilerCategory
Non-accelerated Filer
CY2021Q1 us-gaap Related Party Transaction Due From To Related Party Current
RelatedPartyTransactionDueFromToRelatedPartyCurrent
295000
CY2021Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
180
CY2021Q1 us-gaap Repayments Of Related Party Debt
RepaymentsOfRelatedPartyDebt
295000
CY2021Q1 rtpy Working Capital Loan Outstanding Amount
WorkingCapitalLoanOutstandingAmount
0
CY2021Q1 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt; margin-left: 4%;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Concentration of Credit Risk</div></div></div></div> <div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: &quot;times new roman&quot;; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage limit of $250,000. As of March&#160;31, 2021, the Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>
CY2021Q1 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
E9

Files In Submission

Name View Source Status
0001193125-21-162338-index-headers.html Edgar Link pending
0001193125-21-162338-index.html Edgar Link pending
0001193125-21-162338.txt Edgar Link pending
0001193125-21-162338-xbrl.zip Edgar Link pending
d924182d10q.htm Edgar Link pending
d924182dex106.htm Edgar Link pending
d924182dex107.htm Edgar Link pending
d924182dex108.htm Edgar Link pending
d924182dex109.htm Edgar Link pending
d924182dex311.htm Edgar Link pending
d924182dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R4.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
rtpy-20210331.xml Edgar Link completed
rtpy-20210331.xsd Edgar Link pending
rtpy-20210331_cal.xml Edgar Link unprocessable
rtpy-20210331_def.xml Edgar Link unprocessable
rtpy-20210331_lab.xml Edgar Link unprocessable
rtpy-20210331_pre.xml Edgar Link unprocessable
Show.js Edgar Link pending